Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15109
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp Key Recent Developments

Nov 09,2018: Adamis Pharmaceuticals announces third quarter 2018 financial results and business update
Aug 27,2018: Adamis Pharmaceuticals Provides Business Update
Aug 10,2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update
May 10,2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Mar 15,2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update

This comprehensive SWOT profile of Adamis Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Adamis Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Adamis Pharmaceuticals Corp – Key Information
Adamis Pharmaceuticals Corp – Overview
Adamis Pharmaceuticals Corp – Key Employees
Adamis Pharmaceuticals Corp – Key Employee Biographies
Adamis Pharmaceuticals Corp – Key Operational Heads
Adamis Pharmaceuticals Corp – Major Products and Services
Adamis Pharmaceuticals Corp – History
Adamis Pharmaceuticals Corp – Company Statement
Adamis Pharmaceuticals Corp – Locations And Subsidiaries
Adamis Pharmaceuticals Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Adamis Pharmaceuticals Corp – Business Description
Adamis Pharmaceuticals Corp – Corporate Strategy
Adamis Pharmaceuticals Corp – SWOT Analysis
SWOT Analysis – Overview
Adamis Pharmaceuticals Corp – Strengths
Adamis Pharmaceuticals Corp – Weaknesses
Adamis Pharmaceuticals Corp – Opportunities
Adamis Pharmaceuticals Corp – Threats
Adamis Pharmaceuticals Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Adamis Pharmaceuticals Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Adamis Pharmaceuticals Corp, Key Information
Adamis Pharmaceuticals Corp, Key Ratios
Adamis Pharmaceuticals Corp, Share Data
Adamis Pharmaceuticals Corp, Major Products and Services
Adamis Pharmaceuticals Corp, History
Adamis Pharmaceuticals Corp, Key Employees
Adamis Pharmaceuticals Corp, Key Employee Biographies
Adamis Pharmaceuticals Corp, Key Operational Heads
Adamis Pharmaceuticals Corp, Other Locations
Adamis Pharmaceuticals Corp, Subsidiaries
Adamis Pharmaceuticals Corp, Key Manufacturing facilities
Adamis Pharmaceuticals Corp, Key Competitors
Adamis Pharmaceuticals Corp, SWOT Analysis
Adamis Pharmaceuticals Corp, Ratios based on current share price
Adamis Pharmaceuticals Corp, Annual Ratios
Adamis Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Adamis Pharmaceuticals Corp, Performance Chart
Adamis Pharmaceuticals Corp, Ratio Charts

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, …
  • Luzhou Bio-chem Technology Limited:企業の戦略・SWOT・財務分析
    Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report Summary Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Euler Hermes SA:戦略・SWOT・企業財務分析
    Euler Hermes SA - Strategy, SWOT and Corporate Finance Report Summary Euler Hermes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • La Mancha Holding SaRL:企業の戦略・SWOT・財務情報
    La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report Summary La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Mitsubishi UFJ Financial Group Inc:企業のM&A・事業提携・投資動向
    Mitsubishi UFJ Financial Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi UFJ Financial Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Alphabet Inc:企業のM&A・事業提携・投資動向
    Alphabet Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alphabet Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Albany Molecular Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclini …
  • Vestas Wind Systems AS (VWS)-エネルギー分野:企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • Atopix Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Diehl Stiftung & Co. KG:企業の戦略・SWOT・財務情報
    Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Bangkok Chain Hospital Public Co Ltd (BCH):企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Strauss Group Ltd.:企業の戦略・SWOT・財務情報
    Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company's therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 …
  • Janssen Biotech, Inc.:企業のM&A・事業提携・投資動向
    Janssen Biotech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Janssen Biotech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Symphony Ltd:企業の戦略・SWOT・財務情報
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TSI Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆